Citadel Advisors’s WisdomTree BioRevolution Fund WDNA Stock Holding History

Citadel Advisors’s Portfolio WDNA Stock Details WDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-13,178	Closed	-$222K	–	15516
2023 Q4	$222K	Sell	13,178 -5,957	-31%	-$89.9K	﹤0.01%	9738
2023 Q3	$290K	Buy	19,135 +280	+1%	+$4.72K	﹤0.01%	9247
2023 Q2	$329K	Sell	18,855 -822	-4%	-$14.3K	﹤0.01%	8851
2023 Q1	$338K	Sell	19,677 -33	-0.2%	-$578	﹤0.01%	9138
2022 Q4	$342K	Buy	19,710 +4,574	+30%	+$81.1K	﹤0.01%	9026
2022 Q3	$255K	Buy	15,136 +3,030	+25%	+$56K	﹤0.01%	9931
2022 Q2	$210K	Buy	+12,106	New	+$219K	﹤0.01%	10607

Other funds holding WDNA

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citadel Advisors's WDNA Position: Q1 2024 in Review

Citadel Advisors sold out of WisdomTree BioRevolution Fund (WDNA) in Q1 2024, closing a stake of 13,178 shares — an estimated $222K sold.

Citadel Advisors first reported a position in WDNA in Q2 2022 and held it in 7 quarters. The position peaked at $342K in Q4 2022. 3 funds tracked by Wall St. Rank hold WDNA as of Q1 2024.

Citadel Advisors reported no remaining WisdomTree BioRevolution Fund position as of Q1 2024 after selling out during the quarter.
Citadel Advisors sold 13,178 WisdomTree BioRevolution Fund shares in Q1 2024, an estimated $222K.
Citadel Advisors first reported a position in WisdomTree BioRevolution Fund in Q2 2022 and held it in 7 quarters.
Citadel Advisors's WisdomTree BioRevolution Fund position peaked at $342K in Q4 2022.
3 funds tracked by Wall St. Rank held WisdomTree BioRevolution Fund as of Q1 2024.

Based on Citadel Advisors's 13F filing for Q1 2024, filed 15 May 2024.